Literature DB >> 8074257

Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys.

W E Collins1, G G Galland, J S Sullivan, C L Morris.   

Abstract

Three strains of Plasmodium falciparum, Vietnam Oak Knoll (FVO), Uganda Palo Alto (Hawaii) (FUP-H) and Uganda Palo Alto (Cayenne) (FUP-C), were examined in 154 Aotus nancymai monkeys as suitable models for testing blood-stage vaccines. The Vietnam Oak Knoll strain had the greatest number of animals with maximum parasite counts > 200,000/microliters. Uniformity of the parasitemia curve increased from passage 4 to passage 6 with an accompanying decrease in the number of days required to reach maximum parasitemia or required treatment. The Uganda Palo Alto (Hawaii) strain was highly infectious, but many animals had extended prepatent periods and extended days to maximum parasitemia. The FUP-H strain would require a greater number of animals per test group to detect partial protection because of the greater number of low-density maximum parasite counts in control animals. The Uganda Palo Alto (Cayenne) strain was poorly adapted to intact A. nancymai. However, five of six splenectomized monkeys inoculated during passage 6 with 10(5) parasites had maximum parasite counts > 200,000/microliters. For the testing of vaccines against primary parasitemia in the A. nancymai model system, the FVO at passage 4 level would appear preferable to passage 6 parasites following a challenge with 10(5) parasites. A similar pattern could be obtained using FUP-H if the challenge was 10(6) parasites. To measure immune memory against recrudescence or rechallenge infection, FUP-C at an early passage in splenectomized A. nancymai would appear to be the appropriate model.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8074257     DOI: 10.4269/ajtmh.1994.51.224

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.

Authors:  B L Perlaza; M Arévalo-Herrera; K Brahimi; G Quintero; J C Palomino; H Gras-Masse; A Tartar; P Druilhe; S Herrera
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

2.  Immunization of Aotus monkeys with recombinant Plasmodium falciparum hybrid proteins does not reproducibly result in protection from malaria infection.

Authors:  C H Kocken; E Hundt; B Knapp; D Brazel; B Enders; D L Narum; J A Wubben; A W Thomas
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

3.  High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.

Authors:  Sheetij Dutta; JoAnn S Sullivan; Katharine K Grady; J David Haynes; Jack Komisar; Adrian H Batchelor; Lorraine Soisson; Carter L Diggs; D Gray Heppner; David E Lanar; William E Collins; John W Barnwell
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

4.  Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

Authors:  S Kumar; A Yadava; D B Keister; J H Tian; M Ohl; K A Perdue-Greenfield; L H Miller; D C Kaslow
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

5.  Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria.

Authors:  Clemens H M Kocken; Edmond J Remarque; Martin A Dubbeld; Sharon Wein; Annemarie van der Wel; R Joyce Verburgh; Henri J Vial; Alan W Thomas
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

6.  Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.

Authors:  G S Hui; C Nikaido; C Hashiro; D C Kaslow; W E Collins
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

7.  The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.

Authors:  Christian A Darko; Evelina Angov; William E Collins; Elke S Bergmann-Leitner; Autumn S Girouard; Stacy L Hitt; Jana S McBride; Carter L Diggs; Anthony A Holder; Carole A Long; John W Barnwell; Jeffrey A Lyon
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi.

Authors:  Victoria C Barclay; Derek Sim; Brian H K Chan; Lucas A Nell; Maia A Rabaa; Andrew S Bell; Robin F Anders; Andrew F Read
Journal:  PLoS Biol       Date:  2012-07-31       Impact factor: 8.029

9.  A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.

Authors:  Alexander D Douglas; G Christian Baldeviano; Carmen M Lucas; Luis A Lugo-Roman; Cécile Crosnier; S Josefin Bartholdson; Ababacar Diouf; Kazutoyo Miura; Lynn E Lambert; Julio A Ventocilla; Karina P Leiva; Kathryn H Milne; Joseph J Illingworth; Alexandra J Spencer; Kathryn A Hjerrild; Daniel G W Alanine; Alison V Turner; Jeromy T Moorhead; Kimberly A Edgel; Yimin Wu; Carole A Long; Gavin J Wright; Andrés G Lescano; Simon J Draper
Journal:  Cell Host Microbe       Date:  2015-01-14       Impact factor: 21.023

10.  Mid-Liver Stage Arrest of Plasmodium falciparum Schizonts in Primary Porcine Hepatocytes.

Authors:  Saskia C van der Boor; Geert-Jan van Gemert; Alex E J Hanssen; Youri M van Waardenburg; Matthew B B McCall; Teun Bousema; Johannes H W de Wilt; Robert W Sauerwein; Annie S P Yang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-17       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.